Benny Mrnustik
Family Medicine · Rowlett, TXNPI 1093773558
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations.
Across 131 payments — averaging $14.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$350
- Novo Nordisk$325
- AstraZeneca$265
- Pfizer$141
- AbbVie$140
- Boehringer Ingelheim$76
- plus $579 from 21 others
What the payments were for
- Food & beverage$1,84098%
- Education$362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 21 | $350 |
| Novo Nordisk | 31 | $325 |
| AstraZeneca | 19 | $265 |
| Pfizer | 11 | $141 |
| AbbVie(2 entities) | 7 | $140 |
| Boehringer Ingelheim | 5 | $76 |
| GSK | 5 | $73 |
| Johnson & Johnson | 5 | $69 |
| Gilead | 2 | $59 |
| Ironshore Pharmaceuticals Inc. | 3 | $41 |
| Novartis | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $37 |
| Optinose US, Inc. | 2 | $29 |
| Merck | 2 | $23 |
| Antares Pharma, Inc. | 1 | $19 |
| Nalpropion Pharmaceuticals LLC | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
| Melinta Therapeutics, LLC | 1 | $12 |
How this compares
$1,876 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Rowlett
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.